skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Testing whether drugs that weaken norepinephrine signaling prevent or treat various types of cancer

Commentary

(3061) Views  (662) Full article downloads

Authors: Paul J Fitzgerald

Published Date December 2009 Volume 2010:2 Pages 1 - 3
DOI: http://dx.doi.org/10.2147/CLEP.S8903

Paul J Fitzgerald

The Zanvyl Krieger Mind/Brain Institute, Solomon H. Snyder, Department of Neuroscience, Johns Hopkins University, Baltimore, MD, USA

Abstract: Recently, I put forth the hypothesis that the signaling molecule, norepinephrine (NE), is an etiological factor in a number of types of cancer. In this brief commentary, I summarize evidence that NE plays a role in cancer and describe details involved in testing the hypothesis in humans through epidemiological investigation of existing medical records of persons who have taken pharmaceutical drugs that affect NE. If NE plays an etiological role in cancers of a number of organs, then taking a single pharmaceutical drug (such as clonidine, prazosin, or propranolol) that weakens NE signaling systemically, may simultaneously prevent or treat many different types of cancer, and this may represent a breakthrough in pharmaceutical prevention and possibly treatment of cancer.

Keywords: norepinephrine, acetylcholine, cancer, clonidine, prazosin, propranolol








Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
ABO and rhesus blood group distribution in Kurds
Anesthesiologists’ perception of patients’ anxiety under regional anesthesia
Saxagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus
Levodopa in the treatment of Parkinson’s disease: an old drug still going strong
Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography
Nanostructured delivery system for zinc phthalocyanine: preparation, characterization, and phototoxicity study against human lung adenocarcinoma A549 cells
The western diet and lifestyle and diseases of civilization
Green synthesis and characterization of gelatin-based and sugar-reduced silver nanoparticles
Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports